Heroic work went into the development of the coronavirus vaccines. But that doesn’t mean this industry deserves your affection.
These non-pharmaceutical treatments are proven effective, and in some cases, are creating a large hole in the lock that big pharma has on treatment options.
Lots of people in the healthcare field heaved a sigh of relief last week when President Trump nominated Scott Gottlieb, a physician, venture investor and former official of the Food and Drug Administration, to be the FDA’s next commissioner. It comes as no surprise that Big Pharma is very, very happy.